Moreover, a recent study indicated that the transplantation with neural precursor cells derived from SUPT4H1 gene-edited iPS cells exhibited promising therapeutic effects in a mouse model for Huntington’s disease [30]. Here, SUPT4H1 is linked to juvenile Huntington disease.